Financhill
Back

Boundless Bio Stock Predictions

Boundless Bio Stock Forecast

  • Is Boundless Bio Stock Undervalued?
    The current Boundless Bio [BOLD] share price is $9.05. The Score for BOLD is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • BOLD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Boundless Bio Stock Go Up Next Year?

Data Unavailable

Boundless Bio Stock Rating

Data Unavailable

Boundless Bio Stock Price History

Is BOLD stock going to rise?

  • The current trend is relatively stagnant and BOLD is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
boundlessbio.com

52-Week Data

52-Week High:
15.24
52-Week Low:
8.97

Prediction Charts

Market Cap:
201.27M
Price in USD:
9.05
Volume:
149.39K
Beta:
0.00

Technical Analysis

SMA50:
0.00
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
0%

Stock Predictions

  • Is Boundless Bio stock public?
    Yes, Boundless Bio is a publicly traded company.
  • What is the Boundless Bio stock quote today?
    The Boundless Bio stock price is 9.05 USD today.
  • How to buy Boundless Bio stock online?
    You can buy Boundless Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-15 11.35 10.79 11.44 10.35
Apr-16 10.60 10.52 10.98 10.35
Apr-17 10.45 11.25 11.59 10.45
Apr-18 11.77 11.30 11.90 11.17
Apr-19 11.50 10.07 11.50 9.94
Apr-22 9.90 10.01 10.61 9.83
Apr-23 9.97 10.66 10.91 9.97
Apr-24 10.86 11.03 11.21 10.03
Apr-25 10.80 12.07 12.18 10.44
Apr-26 12.18 11.64 12.65 11.21
Apr-29 11.94 11.46 11.97 10.86
Apr-30 11.14 9.85 11.84 9.85
May-1 9.84 10.00 10.39 8.97
May-2 10.03 9.05 10.36 8.99

Boundless Bio Earnings

Data Unavailable

Boundless Bio Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.83 per share.

* Boundless Bio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.